AlphaQuest LLC Sells 65,709 Shares of Sabra Healthcare REIT, Inc. $SBRA

AlphaQuest LLC trimmed its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 45.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 79,130 shares of the real estate investment trust’s stock after selling 65,709 shares during the quarter. AlphaQuest LLC’s holdings in Sabra Healthcare REIT were worth $1,499,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of SBRA. Founders Capital Management bought a new stake in Sabra Healthcare REIT during the 3rd quarter valued at approximately $28,000. Strengthening Families & Communities LLC bought a new stake in Sabra Healthcare REIT during the 4th quarter valued at approximately $29,000. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth approximately $30,000. Larson Financial Group LLC boosted its position in shares of Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares in the last quarter. Finally, First Horizon Corp bought a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth approximately $44,000. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $20.45 on Thursday. Sabra Healthcare REIT, Inc. has a twelve month low of $17.13 and a twelve month high of $21.28. The firm has a market cap of $5.16 billion, a P/E ratio of 32.46, a PEG ratio of 1.56 and a beta of 0.67. The company has a 50 day moving average of $20.32 and a 200 day moving average of $19.69. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $221.75 million during the quarter, compared to analyst estimates of $209.20 million. During the same period in the previous year, the business earned $0.37 EPS. The firm’s revenue for the quarter was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 29th. Shareholders of record on Friday, May 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 5.9%. Sabra Healthcare REIT’s payout ratio is 190.48%.

Analysts Set New Price Targets

A number of brokerages have recently commented on SBRA. Truist Financial boosted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, March 13th. Cantor Fitzgerald boosted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Citizens Jmp boosted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a research report on Wednesday, February 18th. Weiss Ratings cut Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Friday, May 1st. Finally, Scotiabank boosted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “sector perform” rating in a research report on Thursday, May 21st. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $22.30.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.